Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron and Occlusal Splint for Myofascial Pain in TMD
NCT07401745Phase 4Active, not recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of granisetron in temporomandibular disorder (TMD), myofascial pain syndrome (MPS), sponsored by Mansoura University. Started Jan 2026; status: active, not recruiting.
02
Drugs
granisetron
03
Conditions
temporomandibular disorder (TMD)myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07401745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401745.